The Bridging Antiplatelet Therapy With Cangrelor 2 Study
NCT07225842
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Coronary Arterial Disease (CAD)
Interventions
DRUG:
Cangrelor
Sponsor
University of Florida